OUR COMMITMENT TO OPENNESS
The European Charcot-Marie-Tooth Federation (ECMTF) is committed to accountable governance, independent patient advocacy and transparent reporting of its funding. Explore how we consult our members, safeguard our independence and disclose our financial resources.
Accountability and consultation
ECMTF is a federation of patient organisations. Its constitution establishes how member organisations are represented and involved in decision-making.
Member representation
Member organisations appoint delegates to represent them within the Federation. Full Members have voting rights at General Meetings; Associate Members may participate without voting rights.
Consultation and decisions
The General Assembly meets at least annually. Members receive advance notice, proposed resolutions, and other relevant documents. Its responsibilities include approving annual accounts and electing the Board.
Oversight and reporting
The Board of Directors administers ECMTF and reports through established governance procedures. Meeting minutes and decisions are documented and communicated to members in accordance with the statutes.
02 / ETHICS & INDEPENDENCE
Our Code of Practice
ECMTF’s Code of Practice sets out the principles governing its relationships with the healthcare and pharmaceutical industries. It addresses independent decision-making, transparent acknowledgement of funding, protection from product promotion and safeguards for sponsored activities.
Financial support must not give any funder control over ECMTF’s priorities, public positions, event programmes or choice of speakers.
Coming soon..Based on the principles of the EURORDIS Code of Practice between Patient Organisations and the Healthcare Industry.
How we are funded
2025 financial year · Based on the ECMTF 2025 Accounts. Percentages are calculated against income generated during 2025, excluding the balance carried forward from 2024.
FUNDING COMPOSITION
Industry vs non-industry
Funding from three healthcare-industry companies, alongside European public funding, membership fees, bank interest and private donations from private individuals.
PUBLIC FUNDING SHARE
European Union support
EU4Health grant supporting the 2nd European CMT Specialists Conference.
FUNDING CONCENTRATION
Largest company contribution
Applied Therapeutics: €20,000.00 of total annual income.
All reported income sources · 2025
Exact figures from the annual accounts; percentages shown to two decimals.
| Source | Classification | 2025 income | Share of total |
|---|---|---|---|
| European Union · EU4Health (2nd European CMT Specialists Conference) | Public | €20,284.63 | 37.62% |
| Applied Therapeutics | Industry | €20,000.00 | 37.10% |
| Ulysses Neuroscience Ltd | Industry | €5,000.00 | 9.27% |
| Full Member organisations (aggregate) | Non-industry | €3,012.94 | 5.59% |
| Interest income (Belfius Bank accounts) | Non-industry | €2,598.23 | 4.82% |
| NMD Pharma | Industry | €2,000.00 | 3.71% |
| Associate Member organisations (aggregate) | Non-industry | €582.77 | 1.08% |
| Private individual donations (aggregate) | Non-industry | €435.61 | 0.81% |
| Total annual income | €53,914.18 | 100.00% | |
Membership fees and private donations are presented as aggregate amounts in the 2025 Accounts. ECMTF has confirmed that the €435.61 donations originated from private individual donors.
Healthcare-industry supporters · 2025
Companies whose 2025 contributions are recorded as conference grants in the ECMTF accounts.

Applied Therapeutics

Ulysses Neuroscience Ltd

NMD Pharma
Industry contributions were primarily allocated to the 2025 specialist conference as unconditional support. Sponsor acknowledgement does not constitute endorsement of any company, medicine, product or service. The percentages above use total annual income, not the industry-only funding subtotal.
Public funding · European Union
ECMTF received €20,284.63 through EU4Health for the 2nd European CMT Specialists Conference (2025), equivalent to 37.62% of annual income. The event was co-funded under grant agreement 101232916.
View the conference and funding acknowledgementAnnual accounts & reports
Download ECMTF’s last 5 year annual financial statements.
Funding disclosures refer to funds received by ECMTF during the reporting year. Other event supporters may be acknowledged separately where their contributions did not constitute ECMTF income.